It Is Time to Stop Using Epirubicin to Treat Any Patient With Gastroesophageal Adenocarcinoma. Article uri icon

Overview

publication date

  • October 28, 2016

Research

keywords

  • Adenocarcinoma
  • Esophageal Neoplasms
  • Stomach Neoplasms

Identity

Scopus Document Identifier

  • 85019994594

Digital Object Identifier (DOI)

  • 10.1200/JCO.2016.69.7276

PubMed ID

  • 28129519

Additional Document Info

volume

  • 35

issue

  • 4